info@drawbridgepharmaceuticals.com.au

Drawbridge Pharmaceuticals

  • Home
  • Our Team
  • Products
  • Publications
  • News
  • investors

Products

 

Phaxan™:Intravenous Anaesthetic & Sedative

Phaxan™ in Critical Care Neurology

IP Position

IP Position

Drawbridge has a robust intellectual property position on Phaxan™. A PCT was filed in January 2011 with national phase filings proceeding worldwide in key jurisdictions. Patents arising from PCT/AU2011/00050, entitled “Anaesthetic Formulation” have been granted in Australia, China, Hong Kong, New Zealand, Singapore, South Africa, United Kingdom and the United States of America.
  • Home
  • Our Team
  • Products
  • Publications
  • News
  • investors
  • Contact

Copyright © 2021 Drawbridge Pharmaceuticals